MYCN and neuroblastoma: As toxic therapeutic interventions such as chemotherapy and radiation therapy can stunt growth and delay pubertal onset in neuroblastoma survivors, relationships between these anthropometric variables and neuroblastoma risk are typically confounded by the effects of treatment, which is particularly aggressive in cases of MYCN‐amplified neuroblastoma.